Berndt Modig, Chief Executive Officer and Director of Pharvaris N.V. (NASDAQ:PHVS), filed a Form 4 on August 18, 2026, reporting a sale of common stock on August 14, 2026, executed pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Shares sold: 2,292 shares of common stock were disposed of on August 14, 2026, at a price of $34.7669 per share.
  • 10b5-1 plan: According to the filing, the sale was made pursuant to a Rule 10b5-1 trading plan and the shares were acquired upon vesting of restricted stock units.
  • Direct ownership after transaction: Modig directly holds 130,625 shares of common stock following the reported transaction.
  • Indirect ownership: Modig also holds 950,000 shares indirectly through Schoodic Management BV, an entity the filing states is controlled by Mr. Modig.
  • Roles: The reporting person is identified as both a Director and Chief Executive Officer of Pharvaris N.V.

Pharvaris CEO Modig Transaction Details and Beneficial Ownership

According to the Form 4 filed with the SEC on August 18, 2026, Berndt Modig sold 2,292 shares of Pharvaris N.V. common stock on August 14, 2026, at a price of $34.7669 per share. The filing notes that the shares were acquired upon the vesting of restricted stock units and that the sale was conducted pursuant to a Rule 10b5-1 trading plan, as indicated by the checkbox marked on the form.

Following the reported transaction, Modig directly owns 130,625 shares of common stock in Pharvaris N.V. In addition, the filing discloses indirect beneficial ownership of 950,000 shares held through Schoodic Management BV, described in the filing as "an entity controlled by Mr. Modig." No derivative securities transactions were reported in Table II of the filing.

The Form 4 was signed by Marnus Nel as Attorney-in-Fact for Berndt Modig on August 18, 2026. The filing was made in connection with Section 16(a) of the Securities Exchange Act of 1934, which requires officers and directors to disclose changes in their beneficial ownership of issuer securities.

What Was Disclosed

Pharvaris N.V. CEO Berndt Modig reported a disposition of 2,292 shares at $34.7669 each on August 14, 2026, under a Rule 10b5-1 plan, with direct post-transaction holdings of 130,625 shares and indirect holdings of 950,000 shares via Schoodic Management BV.